Perrine Constance E
Known title: SVP & CAOCIK: 0001363166
Perrine Constance E's purchase track record
Perrine Constance E has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/14/2023 | CBNK | $77 | +1.8% | +28.7% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CBNK | ▲ Buy | Option Exercise | 250 | $3K | 10/11/2023 | View on chart |
| CBNK | ▲ Buy | Open Market | 4 | $77 | 6/14/2023 | View on chart |
| CBNK | ▲ Buy | Option Exercise | 1,500 | $17K | 5/8/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
CBNK peers in M&A talks; Capital Bancorp trades near 52-week high
Recent news highlights active merger and acquisition discussions among regional banks, specifically noting Peoples Bancorp's deal talks and valuation analysis. While these articles focus on a peer, they underscore a broader trend of consolidation in the banking sector that often affects sentiment for similar institutions like Capital Bancorp. CBNK is currently trading near its 52-week high, with a trailing P/E of 11.5 and an average analyst target of $41.94.
CBNK peers in M&A talks; Capital Bancorp trades near 52-week high. Recent news highlights active merger and acquisition discussions among regional banks, specifically noting Peoples Bancorp's deal talks and valuation analysis. While these articles focus on a peer, they underscore a broader trend of consolidation in the banking sector that often affects sentiment for similar institutions like Capital Bancorp. CBNK is currently trading near its 52-week high, with a trailing P/E of 11.5 and an average analyst target of $41.94.